Finch Therapeutics Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Finch Therapeutics's estimated annual revenue is currently $21.1M per year.
- Finch Therapeutics received $36.0M in venture funding in March 2018.
- Finch Therapeutics's estimated revenue per employee is $155,000
- Finch Therapeutics's total funding is $40.5M.
- Finch Therapeutics has 136 Employees.
- Finch Therapeutics grew their employee count by 45% last year.
- Finch Therapeutics currently has 1 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Pricing|
|Cell Signaling ...||$89.4M||577||N/A||N/A||N/A|
What Is Finch Therapeutics?
Finch Therapeutics is unlocking the therapeutic potential of the microbiome through our human-first discovery platform. We use machine learning algorithms to reverse engineer successful fecal transplantations and other clinical datasets, identifying the microbes that drive responses in patients. This human-centric discovery model leverages clinical data to focus our in-vitro and in-vivo efforts on cocktails of microbes that have already demonstrated safety and efficacy in humans. This enables early retirement of translational risk and avoids the challenges of extrapolating host-specific effects from animal models. Our team values transparency, integrity, humility, and collaboration, and we intend to have fun while maximizing our ability to make an impact on patients lives.keywords:N/A
Number of Employees
Employee Growth %
|Sonia Timberlake||Vp Research|
|Tulan Kantesaria||AP & Procurement manager / Senior Accountant (Contract)|
|Josh Grehan||Senior Manager Of Business Operations||Email Available|
|Thomas Smith||Research and Development Operations Manager|
|Elyse Skenderian||Clinical Trial Manager|
|Natalia Outkina||Senior Accounting Manager|
|Yu Yang||Senior Scientist, manager|
|Kristyn Bogli||Associate Director, Program Management|
|Zeba Jamshed||Senior Program Manager, Cmc|
|Crystal Chen||Sr Medical Director|
Finch Therapeutics News
Finch Therapeutics has completed a Series C financing, raising $53m to advance its microbiome therapies pipeline. The Massachusetts-based ...
Finch Therapeutics Raises $53 Million to Advance Microbiome-Based Therapies for Recurrent C. Difficile, Autism and other Disease Areas.
Finch Therapeutics Group, Inc., a Somerville, MA-based clinical-stage microbiome therapeutics company, completed a $53m Series C ...
Finch Therapeutics Funding
Finch Therapeutics Executive Hires
|2018-06-13||Ulrich Thienel||Chief Medical Officer||Article|
Finch Therapeutics Acquisitions